T-cell suicide gene therapy for organ transplantation: Induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression

Molecular Therapy

Volumn 2, Issue 6, 2000, Pages 596-601

  Braunberger, Eric ^a,b   Cohen, José L ^c   Boyer, Olivier ^c   Pegaz Fiornet, Béatrice ^a   Raynal Raschilas, Nathalie ^a   Bruneval, Patrick ^a   Thomas Vaslin, Véronique ^c   Bellier, Bertrand ^c   Carpentier, Alain ^b   Glotz, Denis ^a   Klatzmann, David ^c  

^a INSERM   (France)

^b Lab d'Etud Greffes Protheses C   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Allotransplantation; Ganciclovir; Graft; HSV1 TK; Mice; Suicide gene; Therapy; Transgenic; Vascularized

Indexed keywords

HERPES; HUMAN HERPESVIRUS 1; MUS MUSCULUS;

GANCICLOVIR; THYMIDINE KINASE;

ADAPTATION; ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; ENZYMOLOGY; GENE THERAPY; GENETICS; HEART TRANSPLANTATION; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MOUSE; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; GANCICLOVIR; GENE THERAPY; HEART TRANSPLANTATION; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034571645     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0208     Document Type: Article

References (28)

1. Fruman, D. A., Klee, C. B., Bierer, B. E., and Burakoff, S. J. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. USA 89: 3686-3690.
2. Patel, R., and Paya, C. V. (1997). Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10: 86-124.
3. Calne, R. (1994). Impact of immunosuppressants on host tissues and tolerance. Transplant. Proc. 26: 3065-3070.
4. Nagano, H., and Tilney, N. L. (1997). Chronic allograft failure: The clinical problem. Am. J. Med. Sci. 313: 305-309.
5. Wood, K. J. (1996). Induction of tolerance to cardiac allografts. Curr. Opin. Cardiol. 11: 208-213.
6. Wood, K. J. (1996). New concepts in tolerance. Clin. Transplant. 10: 93-99.
7. Moolten, F. L. (1994). Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1: 279-287.
8. Fyfe, J. A., Keller, P. M., Furman, P. A., Miller, R. L., and Elion, G. B. (1978). Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253: 8721-8727.
9. St. Clair, M. H., Lambe, C. U., and Furman, P. A. (1987). Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Antimicrob. Agents Chemother. 31: 844-849.
10. Cohen, J. L., Boyer, O., and Klatzmann, D. (1999). Would suicide gene therapy solve the T-cell dilemma of allogeneic bone marrow transplantation? Immunol. Today 20: 172-176.
11. Thomas, E., et al. (1975). Bone-marrow transplantation. N. Engl. J. Med. 292: 832-843.
12. Theobald, M. (1995). Allorecognition and graft-versus-host disease. Bone Marrow Transplant. 15: 489-498.
13. Cohen, J. L., et al. (1997). Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 89: 4636-4645.
14. Helene, M., Lake-Bullock, V., Bryson, J. S., Jennings, C. D., and Kaplan, A. M. (1997). Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene. J. Immunol. 158: 5079-5082.
15. Bordignon, C., et al. (1995). Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum. Gene Ther. 6: 813-819.
16. Tiberghien, P., et al. (1997). Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study. Hum. Gene Ther. 8: 615-624.
17. Link, C. J., et al. (1998). Adoptive immunotherapy for leukemia: Donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. Hum. Gene Ther. 9: 115-134.
18. Thomas-Vaslin, V., et al. (2000). Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene. Transplantation 69: 2154-2161.
19. Braunberger, E., et al. (2000). Tolerance induced without immunosuppression in a T-lymphocyte suicide-gene therapy cardiac allograft model in mice. J. Thorac. Cardiovasc. Surg. 119: 46-51.
20. Salmon, P., Boyer, O., Lores, P., Jami, J., and Klatzmann, D. (1996). Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes. J. Immunol. 156: 1873-1879.
21. Cohen, J. L., et al. (1998). Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase ΔTK gene. Transgenic Res. 7: 321-330.
22. Corry, R. J., Winn, H. J., and Russell, P. S. (1973). Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.
23. Hwang, M. W., et al. (1999). FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 100: 1322-1329.
24. Dahmen, U., et al. (1994). Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 58: 1-8.
25. Choo, J. K., et al. (1997). Species differences in the expression of major histocompatibility complex class II antigens on coronary artery endothelium: Implications for cell-mediated xenoreactivity. Transplantation 64: 1315-1322.
26. Kawai, T., Sachs, D. H., and Cosimi, A. B. (1999). Tolerance to vascularized organ allografts in large-animal models. Curr. Opin. Immunol. 11: 516-520.
27. Bonini, C., et al. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276: 1719-1724.
28. Auchincloss, H., Jr., and Sachs, D. H. (1998). Xenogeneic transplantation. Annu. Rev. Immunol. 16: 433-470.